Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Cytokinetics (CYTK) Long-Term Debt Repayments: 2011-2025

Historic Long-Term Debt Repayments for Cytokinetics (CYTK) over the last 5 years, with Sep 2025 value amounting to $2.7 million.

  • Cytokinetics' Long-Term Debt Repayments rose 1.92% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 79.95%. This contributed to the annual value of $8.7 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Cytokinetics' Long-Term Debt Repayments stood at $2.7 million, which was up 0.48% from $2.7 million recorded in Q2 2025.
  • Cytokinetics' Long-Term Debt Repayments' 5-year high stood at $47.7 million during Q1 2022, with a 5-year trough of $705,000 in Q1 2024.
  • Its 2-year average for Long-Term Debt Repayments is $2.4 million, with a median of $2.7 million in 2024.
  • Data for Cytokinetics' Long-Term Debt Repayments shows a peak YoY surged of 280.43% (in 2025) over the last 5 years.
  • Cytokinetics' Long-Term Debt Repayments (Quarterly) stood at $47.7 million in 2022, then reached $2.7 million in 2024, then climbed by 1.92% to $2.7 million in 2025.
  • Its Long-Term Debt Repayments was $2.7 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.7 million in Q1 2025.